Please login to the form below

Not currently logged in
Email:
Password:

Uniphar acquires specialist sales firm OUTiCO

It will continue to be led by founders Paul Black and Mike Cooper

UnipharPharmaceutical and healthcare services group Uniphar has purchased Bath, UK-based OUTiCO as part of its drive to “provide a fully integrated suite of outsourced activities”.

The multichannel account management and consultancy services firm, which has an annual turnover in excess of €1.3bn, will operate as an independent company within Uniphar’s manufacturer services division.

Padraic Dempsey, Uniphar’s manufacturer services’ managing director, said: “The successful acquisition of Star in 2015 enabled us to deliver talented people for outsourced teams and headcount opportunities.

“OUTiCO brings together the expertise of an ever-expanding team of experienced sales and marketing professionals, industry-leading customer preference data, and digital communication channels.”

The deal will see OUTiCO continue under the leadership of founders Paul Black and Mike Cooper.

Cooper said: “Multichannel account management and OUTiCO have experienced phenomenal growth over the past four years, but we knew we needed a partner with scale and diversity to realise multichannel account management’s enormous potential.

“Significantly for us, the cultural and entrepreneurial synergy between ourselves, Uniphar and Star makes this a natural fit.”

Uniphar acquired pharmaceutical and medical resourcing firm Star, which is also based in Bath, in 2015.

Article by
Gemma Jones

9th May 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics